References
- World Malaria Report 2017. Geneva: World Health Organization; 2017. Available from: http://apps.who.int/iris/bitstream/handle/10665/259492/9789241565523-eng.pdf;jsessionid=447BD304DF95E7121284E0614B747C87?sequence=1
- Nussenzweig RS, Vanderberg J, Most H, et al. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature. 1967;216:160–162.
- Mordmuller B, Surat G, Lagler H, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445–449.
- Roestenberg M, Teirlinck AC, McCall MB, et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet. 2011;377:1770–1776.
- Olotu A, Fegan G, Wambua J, et al. Seven-year efficacy of RTS,S/AS01 malaria vaccine among young african children. N Engl J Med. 2016;374:2519–2529.
- Hviid L. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria. Expert Rev Vaccines. 2011;10:1405–1414.
- Rogerson SJ, Hviid L, Duffy PE, et al. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007;7:105–117.
- Hviid L, Jensen AT. PfEMP1 - a parasite protein family of key importance in Plasmodium falciparum malaria immunity and pathogenesis. Adv Parasitol. 2015;88:51–84.
- Seydel KB, Kampondeni SD, Valim C, et al. Brain swelling and death in children with cerebral malaria. N Engl J Med. 2015;372:1126–1137.
- Turner L, Lavstsen T, Berger SS, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature. 2013;498:502–505.
- Bernabeu M, Smith JD. EPCR and malaria severity: the center of a perfect storm. Trends Parasitol. 2017;33:295–308.
- Bernabeu M, Danziger SA, Avril M, et al. Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomass. Proc Natl Acad Sci USA. 2016;113:E3270–E3279.
- Mkumbaye SI, Wang CW, Lyimo E, et al. The severity of Plasmodium falciparum infection is associated with transcript levels of var genes encoding EPCR-binding PfEMP1. Infect Immun. 2017;85:e00841–16.
- Kessler A, Dankwa S, Bernabeu M, et al. Linking EPCR-binding PfEMP1 to brain swelling in pediatric cerebral malaria. Cell Host Microbe. 2017;22:601–614 e5.
- Lau CK, Turner L, Jespersen JS, et al. Structural conservation despite huge sequence diversity allows EPCR binding by the malaria PfEMP1 family. Cell Host Microbe. 2015;17:118–129.
- Lennartz F, Adams Y, Bengtsson A, et al. Structure-guided identification of a family of dual receptor-binding PfEMP1 that is associated with cerebral malaria. Cell Host Microbe. 2017;21:403–414.
- Olsen RW, Ecklu-Mensah G, Bengtsson A, et al. Natural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a Plasmodium falciparum PfEMP1 subtype associated specifically with cerebral malaria. Infect Immun. 2018;86:e00622–17.
- Craig AG, Grau GE, Janse C, et al. The role of animal models for research on severe malaria. PLoS Pathog. 2012;8:e1002401.
- Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet. 2018;391:1608–1621.
- Goncalves BP, Prevots DR, Kabyemela E, et al. Preparing for future efficacy trials of severe malaria vaccines. Vaccine. 2016;34:1865–1867.